Market Place
Sourcing Support
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
02 Nov 2024 //
FIERCE PHARMA
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Study
25 Oct 2024 //
BIOSPACE
Novo asks US to stop compounding weight-loss drug copies
24 Oct 2024 //
REUTERS
Novo oral diabetes drug cuts heart-related risks by 14% in study
22 Oct 2024 //
REUTERS
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
15 Oct 2024 //
FIERCE BIOTECH
Wegovy maker Novo bets big on talent, AI partnerships in India
11 Oct 2024 //
ECONOMICTIMES
WeightWatchers to offer compounded version of Novo`s weight-loss drug
08 Oct 2024 //
REUTERS
Novo settles with Mylan over potential Ozempic generic
07 Oct 2024 //
FIERCE PHARMA
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
26 Sep 2024 //
FIERCE PHARMA
US Senator Sanders says middlemen won`t punish Novo
25 Sep 2024 //
REUTERS
Novo CEO, Sanders to Face Off Over US Prices for Ozempic and Wegovy
24 Sep 2024 //
BIOSPACE
Novo: Ozempic Eligible For US Price Negotiations Soon
23 Sep 2024 //
REUTERS
Novo Nordisk Shares Drop On Disappointing Obesity Pill Data
21 Sep 2024 //
REUTERS
EU regulator backs use of Novo`s Wegovy for obesity-related heart condition
20 Sep 2024 //
REUTERS
Novo Nordisk: Wegovy® Recommended For Label Update In EU
19 Sep 2024 //
GLOBENEWSWIRE
Hims & Hers offers compounded Wegovy for $99 a month to select professions
18 Sep 2024 //
REUTERS
Novo Nordisk Reports Strong Weight Loss Results For Dual-Acting Oral Drug
11 Sep 2024 //
FIERCE BIOTECH
Enforcement Report - Week of September 11, 2024
11 Sep 2024 //
FDA
Novo Nordisk To Present New Diabetes And Obesity Data At EASD Meeting
06 Sep 2024 //
PR NEWSWIRE
Fake Ozempic: Batch Numbers Help Spread Dangerous Weight Loss Drugs
05 Sep 2024 //
REUTERS
FDA Confirms Para IV Patent Litigation for (Rybelsus) Semaglutide
04 Sep 2024 //
FDA
From the Neuland Reading Room: Peptide Trends in 2024
02 Sep 2024 //
PRESS RELEASE
Novo Nordisk`s Ozempic shortage expected to continue into Q4
02 Sep 2024 //
REUTERS
Novo rekindles heart failure hopes for semaglutide with new pooled analysis
31 Aug 2024 //
FIERCE PHARMA
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually
28 Aug 2024 //
BIOSPACE
ProLynx Reports Preclinical Results Of Monthly Semaglutide
21 Aug 2024 //
GLOBENEWSWIRE
New Study Adds To Ongoing Debate On Suicidal Ideation Risk For Ozempic
20 Aug 2024 //
FIERCE PHARMA
Novo Nordisk plans new $220M raw ingredients plant in Denmark
16 Aug 2024 //
FIERCE PHARMA
DiagnaMed Explores Brain Health AI For Weight Loss Drugs Like Semaglutide
15 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk Plans 2024 FDA Filing For Weekly Insulin-Semaglutide Combo
13 Aug 2024 //
FIERCE PHARMA
Novo`s older obesity drug shows biological effect on Alzheimer`s patients
31 Jul 2024 //
REUTERS
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics
30 Jul 2024 //
BIOSPACE
Compounded Injectable Semaglutide Dosing Errors Cause Adverse Events
29 Jul 2024 //
CONTRACT PHARMA
Wegovy Label Updated To Include Cardiovascular Risk Reduction
25 Jul 2024 //
GLOBENEWSWIRE
Novo New Facility With 200-Acre Land Buy In Denmark Amid Weight Loss Drug Boom
23 Jul 2024 //
FIERCE PHARMA
Patients on weight-loss drugs should inform doctor before surgery, EU regulator
13 Jul 2024 //
REUTERS
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
12 Jul 2024 //
FIERCE PHARMA
The most valuable R&D projects? You guessed it: obesity
12 Jul 2024 //
FIERCE BIOTECH
Ozempic linked with lower dementia risk, nicotine use, British study finds
12 Jul 2024 //
REUTERS
Novo Nordisk, Indonesia`s Bio Farma sign deal to produce insulin
10 Jul 2024 //
REUTERS
Sellers of fake Ozempic to face charges in Austrian court
09 Jul 2024 //
REUTERS
Diabetes patients on GLP-1s instead of insulin have lower cancer risk
05 Jul 2024 //
REUTERS
Wegovy, Ozempic linked with sight-threatening eye disorder in study
04 Jul 2024 //
REUTERS
FDA Orders Online Retailer To Stop Selling Unapproved Weight-Loss Drugs
03 Jul 2024 //
RAPS
Lilly, Novo rank 3rd and 4th on list of associated with weight loss drugs in US
02 Jul 2024 //
FIERCE PHARMA
US FDA warns website over unlawful sale of weight-loss drugs
02 Jul 2024 //
REUTERS
Pharma’s Obsession With Obesity On Rise
01 Jul 2024 //
BIOSPECTRUM ASIA
Novo Nordisk wins approval in China for GLP-1 obesity drug Wegovy
26 Jun 2024 //
FIERCE PHARMA
Novo reveals plan to build mammoth $4.1B plant in NC to help produce Ozempic
25 Jun 2024 //
FIERCE PHARMA
Nestle launches website for individuals on weight loss drugs
25 Jun 2024 //
REUTERS
Novo Nordisk`s Wegovy weight-loss drug approved in China
25 Jun 2024 //
REUTERS
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
25 Jun 2024 //
REUTERS
Weight Gain Restarts When Wegovy Stops; Could GLP-1 Gene Therapy Help?
24 Jun 2024 //
FIERCE BIOTECH
Doctors must keep Ozempic prescriptions in check, Danish regulator says
24 Jun 2024 //
REUTERS
Fractyl Health Preclinical Data Rejuva® GLP-1 Therapy ADA 84th Session
23 Jun 2024 //
GLOBENEWSWIRE
WHO issues warnings on fake copies of Novo Nordisk`s weight-loss drugs
21 Jun 2024 //
NCBNEWS
Biocon seeks partner to test generic Wegovy, Ozempic in China
21 Jun 2024 //
MONEYCONTROL
Novo Nordisk To Present Data On Semaglutide At ADA 84th Scientific Sessions
18 Jun 2024 //
GLOBENEWSWIRE
Novo Nordisk CEO agrees to testify on semaglutide pricing
18 Jun 2024 //
PHARMAPHORUM
